Hoshiai H - Search Results

1

Feasibility study of docetaxel and nedaplatin for recurrent squamous cell carcinoma of the uterine cervix.

Watanabe Y, Nakai H, Etoh T, Kanemura K, Tsuji I, Ishizu A, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Anticancer Res. 2008 Jul-Aug;28(4C):2385-8. Anticancer Res. 2008. PMID: 18751423 Free article. Clinical Trial.

2

Evaluation of weekly low-dose paclitaxel and carboplatin treatment for patients with platinum-sensitive relapsed ovarian cancer.

Watanabe Y, Nakai H, Ueda H, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Gynecol Oncol. 2005 Feb;96(2):323-9. doi: 10.1016/j.ygyno.2004.09.029. Gynecol Oncol. 2005. PMID: 15661216 Clinical Trial.

3

Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: a phase I study in Japanese patients with cancer of the uterine cervix.

Watanabe Y, Nakai H, Shimaoka M, Tobiume T, Tsuji I, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Int J Clin Oncol. 2006 Aug;11(4):309-13. doi: 10.1007/s10147-006-0567-4. Int J Clin Oncol. 2006. PMID: 16937305 Clinical Trial.

4

Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer.

Watanabe Y, Koike E, Nakai H, Etoh T, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Int J Clin Oncol. 2008 Aug;13(4):345-8. doi: 10.1007/s10147-008-0765-3. Epub 2008 Aug 15. Int J Clin Oncol. 2008. PMID: 18704636 Clinical Trial.

5

Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study.

Watanabe Y, Hoshiai H, Nakanishi T, Kawamura N, Tanaka N, Isaka K, Kamiura S, Ohmichi M, Hatae M, Ochiai K. Watanabe Y, et al. Among authors: hoshiai h. Anticancer Res. 2011 Sep;31(9):3063-7. Anticancer Res. 2011. PMID: 21868560

6

Carcinomatous meningitis during systematic chemotherapy in a patient with advanced small-cell neuroendocrine carcinoma of the uterine cervix.

Watanabe Y, Nakai H, Imaoka I, Murakami T, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. J Obstet Gynaecol Res. 2012 Jan;38(1):336-9. doi: 10.1111/j.1447-0756.2011.01634.x. Epub 2011 Sep 15. J Obstet Gynaecol Res. 2012. PMID: 21917069

7

[Hemoglobin level and recurrent rate of uterine cervical cancer].

Ueda H, Watanabe Y, Hoshiai H. Ueda H, et al. Among authors: hoshiai h. Nihon Rinsho. 2004 Oct;62 Suppl 10:222-4. Nihon Rinsho. 2004. PMID: 15535239 Review. Japanese. No abstract available.

8

[Recent outline of chemotherapy for uterine endometrial cancer].

Watanabe Y, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Nihon Rinsho. 2004 Oct;62 Suppl 10:346-50. Nihon Rinsho. 2004. PMID: 15535265 Review. Japanese. No abstract available.

9

The effect of granisetron on in vitro metabolism of doxorubicin, irinotecan and etoposide.

Watanabe Y, Nakai H, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Curr Med Res Opin. 2005 Mar;21(3):363-8. doi: 10.1185/030079905X36404. Curr Med Res Opin. 2005. PMID: 15811204

10

Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma.

Ueda H, Watanabe Y, Nakai H, Hemmi H, Koi M, Hoshiai H. Ueda H, et al. Among authors: hoshiai h. Anticancer Res. 2005 Jul-Aug;25(4):2785-8. Anticancer Res. 2005. PMID: 16080527 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters